During the past decade, Austin and Repatriation Medical Centre; Cancer Services conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin and Repatriation Medical Centre; Cancer Services" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Austin and Repatriation Medical Centre; Cancer Services" are "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Transitional Cell" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Austin and Repatriation Medical Centre; Cancer Services" in a lesser frequency.

Most popular intervention types in "Austin and Repatriation Medical Centre; Cancer Services" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin and Repatriation Medical Centre; Cancer Services" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Austin and Repatriation Medical Centre; Cancer Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Austin and Repatriation Medical Centre; Cancer Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Austin and Repatriation Medical Centre; Cancer Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".